Astonea Labs Completes Facility Inspection and Receives Certification from Yemeni Regulatory Body
Astonea Labs Ltd has announced a significant operational milestone, confirming that its manufacturing facility successfully completed an inspection by a key international regulatory body. The company received the requisite certificate today, July 14, 2026, following the inspection.The inspection was conducted by the Supreme Board of Drugs and Medical Appliances (SBDMA), which operates under the Ministry of Health and Population of the Republic of Yemen. This certification confirms the successful completion of the rigorous review process for the facility.
Astonea Labs’ manufacturing unit is situated in Village Haripur, Tehsil Raipur Rani, Panchkula, Haryana - 134204. The achievement marks a crucial step in the company's operational compliance and quality standards.
Stock Price Movement
Astonea Labs Ltd shares settled at ₹287.50, charting a marginal decline of 0.24% on the stock for the day. The shares traded completely flat throughout the session, never deviating from the opening price of ₹287.50.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.